Advances in Melanoma Care: A Multidisciplinary Symposium

Host: The Angeles Clinic and Research Institute (A Cedars-Sinai Affiliate)
Date: Thursday, May 21, 2026 Time: 4:00 PM PT / 5:00 PM MT / 6:00 PM CT / 7:00 PM ET

This 16th annual symposium brings together leading melanoma specialists from The Angeles Clinic, Hadassah Cancer Research Institute., and Massachusetts Brigham General Cancer Institute for a comprehensive afternoon program covering the full spectrum of melanoma care — from surgical and adjuvant approaches through cutting-edge cellular and targeted therapies, with dedicated patient resources and a Q&A session to close.

The program features a strong multidisciplinary lineup — combining medical oncology, surgical oncology, and cellular therapy expertise — anchored by The Angeles Clinic team (Drs. Hamid, Mehmi, and Fischer) with national experts from Memorial Sloan Kettering Cancer Center (Dr. Smithy) Hadassah Cancer Research Institute (Dr. Cohen) and Massachusetts Brigham General Cancer Institute (Dr. Sullivan), plus patient-advocacy representation from AIM at Melanoma.

Key Themes Covered
Treatment sequencing: Adjuvant and neoadjuvant strategies, both medical and surgical
Immunotherapy frontier: T-cell therapies and first-line systemic options
Precision medicine: Targeted therapies for actionable mutations
Special populations: Uveal melanoma and other rare subtypes
What’s next: Novel and emerging therapeutics
Patient support: Community resources via AIM at Melanoma
The symposium runs approximately 2 hours 40 minutes, concluding with an open Q&A for attendees.

Presenters & Topics
4:00 PM PT

Welcome and Introductions
Omid Hamid, MD
Co-Director of Cutaneous Oncology
The Angeles Clinic and Research Institute, A Cedars-Sinai Affiliate

4:10 PM PT

Adjuvant/Neo Adjuvant Therapeutic Considerations
Inderjit Mehmi, MD
Medical Oncologist
The Angeles Clinic and Research Institute, A Cedars-Sinai Affiliate

4:30 PM PT

(Neo) Adjuvant and Metastatic Surgical Considerations
Trevan Fischer, MD
Surgical Oncologist
The Angeles Clinic and Research Institute, A Cedars-Sinai Affiliate

4:50 PM PT

T cell Therapies
James W. Smithy, MD, MHS
Melanoma Medical Oncologist & Cellular Therapist
Memorial Sloan Kettering Cancer Center

5:10 PM PT

First Line Therapies for Advanced Melanoma
Jonathan Cohen, MD, PhD
Senior Medical Oncologist and the Director of Clinical Research
Hadassah Cancer Research Institute

5:30 PM PT

Targeted Therapies
Ryan Sullivan, MD
Director
Center for Melanoma
Massachusetts Brigham General Cancer Institute

5:50 PM PT

Uveal Melanoma & Rare Melanomas
Inderjit Mehmi, MD
Medical Oncologist
The Angeles Clinic and Research Institute, A Cedars-Sinai Affiliate

6:10 PM PT

Novel Therapies in Melanoma
Omid Hamid, MD
Co-Director of Cutaneous Oncology
The Angeles Clinic and Research Institute, A Cedars-Sinai Affiliate

6:30 PM PT

AIM at Melanoma Patient Resources
Ann Garst Taylor, CVA
Director Community Engagement
AIM at Melanoma

6:40 PM PT

Q&A & Closing Remarks

Видео Advances in Melanoma Care: A Multidisciplinary Symposium канала AIMatMelanoma